Bexarotene-activated PPARδ promotes neuroprotection by restoring bioenergetic and quality control homeostasis

nork Dickey, Audrey S., Sanchez, Dafne N., Arreola, Martin, Sampat, Kunal R., Fan, Weiwei, Arbez, Nicolas, Akimov, Sergey, Van Kanegan, Michael J., Ohnishi, Kohta, Gilmore-Hall, Stephen K., Flores, April L., Nguyen, Janice M., Lomas, Nicole, Hsu, Cynthia L., Lo, Donald C., Ross, Christopher A., Masliah, Eliezer, Evans, Ronald M., La Spada, Albert R.
Argitaratua izan da Sci Transl Med (2017)

PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy

nork Dickey, Audrey S., Pineda, Victor V., Tsunemi, Taiji, Liu, Patrick P., Miranda, Helen C., Gilmore-Hall, Stephen K., Lomas, Nicole, Sampat, Kunal R., Buttgereit, Anne, Torres, Mark-Joseph Manalang, Flores, April L., Arreola, Martin, Arbez, Nicolas, Akimov, Sergey S., Gaasterland, Terry, Lazarowski, Eduardo R., Ross, Christopher A., Yeo, Gene W., Sopher, Bryce L., Magnuson, Gavin K., Pinkerton, Anthony B., Masliah, Eliezer, La Spada, Albert R.
Argitaratua izan da Nat Med (2015)